Evidence map›Paper›PMID 41266254›Full record

ArticleJournal of nuclear medicine : official publication, Society of Nuclear Medicine2026

Digital Biopsy and Network Analysis of Dynamic [

Manuel Röhrich, Frederik M Glatting, Magdalena Geisinger, Anna-Maria Spektor, Hans-Georg Buchholz, Joel Wessendorf, Isabelle von Goetze, Jorge Hoppner, Jakob Liermann, Maximilian Knoll and 9 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Parametric mapping of dynamicCancer imaging : the official publication of the International Cancer Imaging Society · 2026
    Article
  2. Bridging Research and Clinical Practice: Automated [Pharmaceuticals (Basel, Switzerland) · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Manuel RöhrichDepartment of Nuclear Medicine, University Hospital Mainz, Mainz, Germany.
Frederik M GlattingDepartment of Radiation Oncology, University Medical Center Mannheim, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany; frederik.glatting@umm.de.
Magdalena GeisingerDepartment of Nuclear Medicine, University Hospital Heidelberg, Heidelberg, Germany.
Anna-Maria SpektorDepartment of Nuclear Medicine, University Hospital Mainz, Mainz, Germany.
Hans-Georg BuchholzDepartment of Nuclear Medicine, University Hospital Mainz, Mainz, Germany.
Joel WessendorfDepartment of Nuclear Medicine, University Hospital Mainz, Mainz, Germany.
Isabelle von GoetzeDepartment of Nuclear Medicine, University Hospital Mainz, Mainz, Germany.
Jorge HoppnerDepartment of Nuclear Medicine, University Hospital Heidelberg, Heidelberg, Germany.
Jakob LiermannDepartment of Radiation Oncology, University Hospital Heidelberg, Heidelberg, Germany.
Maximilian KnollDepartment of Radiation Oncology, University Hospital Heidelberg, Heidelberg, Germany.
Matthias LangDepartment of Surgery, University Hospital Heidelberg, Heidelberg, Germany.
Ulrike HegerDepartment of Surgery, University Hospital Heidelberg, Heidelberg, Germany.
Mathias SchreckenbergerDepartment of Nuclear Medicine, University Hospital Mainz, Mainz, Germany.
Martin LoosDepartment of Surgery, University Hospital Heidelberg, Heidelberg, Germany.
Adriana TavaresCentre for Cardiovascular Science, University of Edinburgh, Edinburgh, United Kingdom.
Klaus HerfarthDepartment of Radiation Oncology, University Hospital Heidelberg, Heidelberg, Germany.
Jürgen DebusDepartment of Radiation Oncology, University Hospital Heidelberg, Heidelberg, Germany.
Uwe HaberkornDepartment of Nuclear Medicine, University Hospital Heidelberg, Heidelberg, Germany.
Mark G MacaskillCentre for Cardiovascular Science, University of Edinburgh, Edinburgh, United Kingdom.

Funding

British Heart Foundation RG/F/22/110093
6 · The paper itself

Abstract

The pathologies pancreatic ductal adenocarcinomas, inflammatory lesions of the pancreas, postpancreatectomy reactive tissue, and recurrent pancreatic ductal adenocarcinomas all express fibroblast activation protein and are hardly distinguishable by static PET using [

Indexed as

Carcinoma, Pancreatic DuctalImage Interpretation, Computer-AssistedNeoplasm Recurrence, LocalPancreatic NeoplasmsPancreatitisQuinolinesAdultAgedAged, 80 and overBiopsyCluster AnalysisDiagnosis, DifferentialFemaleHumansImage Processing, Computer-AssistedMaleFAPI-46QuinolinesRadiopharmaceuticals[68Ga]Ga-FAPIclusteringdynamic PETpancreatic ductal adenocarcinoma

Identifiers

PMID41266254
PMCPMC12866391

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.